DSI telemetry system expansion and upgrade
Ended Awarded Last action
- Contract number
- HT942525FE030
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $36,356
Award facts
- Contract value 100% obligated
- $36,356.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- ABER PROV GRD, MD 21010, USA
Award details come from SAM.gov/FPDS.
About this award
Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a $36,356 firm fixed-price Blanket Purchase Agreement call order by the Defense Health Agency on October 17, 2025, for DSI telemetry system expansion and upgrade work. This task order is issued under Harvard Bioscience's existing $4.8 million single-award BPA with the Defense Health Agency, which was originally awarded in May 2022 and extends through May 3, 2027. The BPA serves as an indefinite delivery vehicle enabling the Defense Health Agency, Army Medical Command, and other military health system partners to procure specialized biomedical research solutions including telemetry equipment, implantable devices, pre-implanted research animals, data acquisition and analysis software, and related technical services. The work will be performed at Aberdeen Proving Ground, Maryland.
This award represents a continuation of Harvard Bioscience's strategic role as a critical supplier of advanced physiological monitoring technologies to the defense and military health sectors. The company, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializes in wireless implantable telemetry transmitters, respiratory monitoring systems, and data acquisition software used in preclinical research. The existing BPA has generated over $1.5 million in cumulative task order value since inception, with individual call orders ranging from approximately $8,320 to $235,556, demonstrating sustained demand for the company's specialized biomedical research capabilities within federal health and defense research programs.
Quick answers
Who was awarded contract HT942525FE030?
HT942525FE030 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on October 17, 2025.
How much is contract HT942525FE030 worth?
The government has obligated $36,356 on HT942525FE030.
Is contract HT942525FE030 an order under another contract?
Yes. HT942525FE030 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT942525FE030 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award